Beneficial effect of TGFbeta antagonism in treating diabetic nephropathy depends on when treatment is started (Q57702774)

From Wikidata

Jump to navigation Jump to search

No description defined

Beneficial Effect of TGFβ Antagonism in Treating Diabetic Nephropathy Depends on When Treatment Is Started

Language	Label	Description	Also known as
English	Beneficial effect of TGFbeta antagonism in treating diabetic nephropathy depends on when treatment is started	No description defined	Beneficial Effect of TGFβ Antagonism in Treating Diabetic Nephropathy Depends on When Treatment Is Started

Statements

scholarly article

0 references

Beneficial effect of TGFbeta antagonism in treating diabetic nephropathy depends on when treatment is started (English)

0 references

Beneficial Effect of TGFβ Antagonism in Treating Diabetic Nephropathy Depends on When Treatment Is Started (English)

0 references

diabetic nephropathy

1 reference

based on heuristic

inferred from title

object named as

Ariela Benigni

1

0 references

Giuseppe Remuzzi

object named as

Giuseppe Remuzzi

10

0 references

4

object named as

Daniela Corna

0 references

2

object named as

Carla Zoja

0 references

8

object named as

Sara Conti

0 references

Daniela Rottoli

6

object named as

Daniela Rottoli

0 references

Elena Gagliardini

7

object named as

Elena Gagliardini

0 references

5

object named as

Fabio Sangalli

0 references

Steve Ledbetter

9

object named as

Steve Ledbetter

0 references

author name string

Marco Campana

3

0 references

language of work or name

0 references

publication date

2006

0 references

11 August 2006

0 references

Nephron Experimental Nephrology

0 references

104

0 references

4

0 references

e158-68

0 references

e158-e168

0 references

Long-term renoprotective effect of angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus. A 7-year follow-up study.

1 reference

https://api.crossref.org/works/10.1159%2F000094967

21 January 2018

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

1 reference

https://api.crossref.org/works/10.1159%2F000094967

21 January 2018

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

1 reference

https://api.crossref.org/works/10.1159%2F000094967

21 January 2018

Effect of combining ACE inhibitor and statin in severe experimental nephropathy

1 reference

https://api.crossref.org/works/10.1159%2F000094967

21 January 2018

Hepatocyte growth factor antagonizes the profibrotic action of TGF-beta1 in mesangial cells by stabilizing Smad transcriptional corepressor TGIF

1 reference

https://api.crossref.org/works/10.1159%2F000094967

21 January 2018

Proximal tubular cells promote fibrogenesis by TGF-beta1-mediated induction of peritubular myofibroblasts

1 reference

https://api.crossref.org/works/10.1159%2F000094967

21 January 2018

Add-on anti-TGF-beta antibody to ACE inhibitor arrests progressive diabetic nephropathy in the rat.

1 reference

https://api.crossref.org/works/10.1159%2F000094967

21 January 2018

Renoprotective benefits of RAS inhibition: from ACEI to angiotensin II antagonists

1 reference

https://api.crossref.org/works/10.1159%2F000094967

21 January 2018

ACE-inhibitors but not endothelin receptor blockers prevent podocyte loss in early diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1159%2F000094967

21 January 2018

Glomerular cell number in normal subjects and in type 1 diabetic patients

1 reference

https://api.crossref.org/works/10.1159%2F000094967

21 January 2018

Antiproteinuric efficacy of losartan in comparison with amlodipine in non-diabetic proteinuric renal diseases: a double-blind, randomized clinical trial

1 reference

https://api.crossref.org/works/10.1159%2F000094967

21 January 2018

Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice

1 reference

https://api.crossref.org/works/10.1159%2F000094967

21 January 2018

Transforming growth factor-beta1 is up-regulated by podocytes in response to excess intraglomerular passage of proteins: a central pathway in progressive glomerulosclerosis

1 reference

https://api.crossref.org/works/10.1159%2F000094967

21 January 2018

Molecular regulation of the bovine endothelial cell nitric oxide synthase by transforming growth factor-beta 1.

1 reference

https://api.crossref.org/works/10.1159%2F000094967

21 January 2018

Identifiers

10.1159/000094967

0 references

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q57702774&oldid=1858272692"